BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29631985)

  • 21. Oral cancer: comprehending the condition, causes, controversies, control and consequences. 4. Potentially malignant disorders of the oral and oropharyngeal mucosa.
    van der Waal I; Scully C
    Dent Update; 2011 Mar; 38(2):138-40. PubMed ID: 21500626
    [No Abstract]   [Full Text] [Related]  

  • 22. [Potentially malignant disorders of the oral mucosa: terminology and classification].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):208-12. PubMed ID: 20739038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical manifestations of oral precancer and cancer.
    Raubenheimer EJ; de Villiers PI
    S Afr Med J; 1989 Feb; Suppl():11-4. PubMed ID: 2916168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the diagnosis of oral premalignant and malignant lesions.
    Epstein JB; Zhang L; Rosin M
    J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of an oral brush biopsy without computer-assisted analysis in the evaluation of oral lesions: a study of 94 patients.
    Mehrotra R; Singh MK; Pandya S; Singh M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):246-53. PubMed ID: 18644521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral precancer: patterns, complexities and clinical guidelines.
    Lovas JG
    J Can Dent Assoc; 1989 Mar; 55(3):209-14. PubMed ID: 2647247
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral precancerous lesions and conditions.
    Wright JM
    Semin Dermatol; 1994 Jun; 13(2):125-31. PubMed ID: 8060824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management.
    van der Waal I
    Oral Oncol; 2010 Jun; 46(6):423-5. PubMed ID: 20308005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computer-assisted analysis of the oral brush biopsy.
    Svirsky JA; Burns JC; Page DG; Abbey LM
    Compend Contin Educ Dent; 2001 Feb; 22(2):99-102, 104, 106; quiz 108. PubMed ID: 11911069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentially malignant oral lesions: clinicopathological correlations.
    Maia HC; Pinto NA; Pereira Jdos S; de Medeiros AM; da Silveira ÉJ; Miguel MC
    Einstein (Sao Paulo); 2016; 14(1):35-40. PubMed ID: 27074232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
    Nagaraju K; Prasad S; Ashok L
    Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukoplakia and erythroplakia of the mouth.
    Ligthelm AJ
    J Dent Assoc S Afr; 1982 Aug; 37(8):515-9. PubMed ID: 6964200
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral Potentially Malignant Disorders.
    Wetzel SL; Wollenberg J
    Dent Clin North Am; 2020 Jan; 64(1):25-37. PubMed ID: 31735231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro examination of suspicious oral lesions using optical coherence tomography.
    Jerjes W; Upile T; Conn B; Hamdoon Z; Betz CS; McKenzie G; Radhi H; Vourvachis M; El Maaytah M; Sandison A; Jay A; Hopper C
    Br J Oral Maxillofac Surg; 2010 Jan; 48(1):18-25. PubMed ID: 19726114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Precancerous lesions of the buccal mucosa].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Various considerations on early cancer of the oral mucosa and its diagnostic techniques].
    Lobos N
    Odontol Chil; 1982; 30(128):138-42. PubMed ID: 6965019
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
    Awan KH; Morgan PR; Warnakulasuriya S
    Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral erythroplakia and erythroleukoplakia: red and red-white dysplastic lesions of the oral mucosa--part 2: cytodiagnosis, pathogenesis, therapy, and prognostic aspects].
    Suter VG; Morger R; Altermatt HJ; Spieler P; Bornstein MM
    Schweiz Monatsschr Zahnmed; 2008; 118(6):510-8. PubMed ID: 18619138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
    Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
    Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.